Stand-Alone COVID-19 Rapid POC Antigen Test Delivers Results in 10 Minutes Without Separate Analyzer
|
By LabMedica International staff writers Posted on 11 Nov 2020 |
|
Image: CareStart COVID-19 Antigen Rapid Point-of-Care test kit (Photo courtesy of AccessBio)
A new minimally-invasive, stand-alone COVID-19 POC antigen test delivers rapid results in 10 minutes without the need for a separate analyzer.
The CareStart COVID-19 Antigen Rapid Point-of-Care (POC) test kit developed and manufactured by AccessBio (Somerset, NJ, USA) allows for rapid, effective screening of COVID-19 infection on a large scale with high sensitivity and 100% specificity. The test is available for immediate purchase by qualified healthcare providers from iRemedy Healthcare Companies, Inc. (Stuart, FL, USA) on www.iremedy.com
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers. Each CareStart kit contains 20 test devices, 20 assay buffers, 20 extraction vials and caps, 20 specimen collection swabs, one positive and one negative control swab and detailed simple use instructions. The stand-alone test has been authorized by the Federal Drug Administration under an Emergency Use Authorization for use by authorized laboratories and at the point-of-care by medical professionals. No separate analyzer equipment is necessary to ascertain results.
“With the second wave of COVID-19 infections underway, it is even more important that healthcare providers have the means to quickly and accurately test and confirm patients who may have contracted the coronavirus,” said Tony Paquin, co-founder and CEO of iRemedy. “Negative test confirmations are just as important, particularly for those essential workers who come into direct contact with the public through their workplaces. iRemedy is very pleased to be offering a rapid point-of-care tool that will empower healthcare providers to perform COVID-19 tests at the point-of-care without the need for specialized materials, equipment, personnel and transportation to a centralized laboratory. As a result, these tests should contribute to improving the containment of COVID-19 spread through faster, more efficient detection and subsequent isolation, when necessary.”
Related Links:
AccessBio
The iRemedy Healthcare Companies, Inc.
 (3) (1).png)
The CareStart COVID-19 Antigen Rapid Point-of-Care (POC) test kit developed and manufactured by AccessBio (Somerset, NJ, USA) allows for rapid, effective screening of COVID-19 infection on a large scale with high sensitivity and 100% specificity. The test is available for immediate purchase by qualified healthcare providers from iRemedy Healthcare Companies, Inc. (Stuart, FL, USA) on www.iremedy.com
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of COVID-19 by their healthcare providers. Each CareStart kit contains 20 test devices, 20 assay buffers, 20 extraction vials and caps, 20 specimen collection swabs, one positive and one negative control swab and detailed simple use instructions. The stand-alone test has been authorized by the Federal Drug Administration under an Emergency Use Authorization for use by authorized laboratories and at the point-of-care by medical professionals. No separate analyzer equipment is necessary to ascertain results.
“With the second wave of COVID-19 infections underway, it is even more important that healthcare providers have the means to quickly and accurately test and confirm patients who may have contracted the coronavirus,” said Tony Paquin, co-founder and CEO of iRemedy. “Negative test confirmations are just as important, particularly for those essential workers who come into direct contact with the public through their workplaces. iRemedy is very pleased to be offering a rapid point-of-care tool that will empower healthcare providers to perform COVID-19 tests at the point-of-care without the need for specialized materials, equipment, personnel and transportation to a centralized laboratory. As a result, these tests should contribute to improving the containment of COVID-19 spread through faster, more efficient detection and subsequent isolation, when necessary.”
Related Links:
AccessBio
The iRemedy Healthcare Companies, Inc.
Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Pipette
Accumax Smart Series
Capillary Blood Collection Tube
IMPROMINI M3
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read more
Molecular Diagnostics
view channel
First Direct Measurement of Dementia-Linked Proteins to Enable Early Alzheimer’s Detection
The disease process in Alzheimer’s begins long before memory loss or cognitive decline becomes apparent. During this silent phase, misfolded proteins gradually form amyloid fibrils, which accumulate in... Read more
New Diagnostic Method Detects Pneumonia at POC in Low-Resource Settings
Pneumonia continues to be one of the leading causes of death in low- and middle-income countries, where limited access to advanced laboratory infrastructure hampers early and accurate diagnosis.... Read more
Hematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Immunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read more
Microbiology
view channel
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read more
Pathology
view channel
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read more
Technology
view channel
Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
Early diagnosis of psychiatric disorders such as depression, schizophrenia, and bipolar disorder remains one of medicine’s most pressing challenges. Current diagnostic methods rely heavily on clinical... Read more
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read more
Industry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more
